Arginine vasopressin prevents amyloid β protein-induced impairment of long-term potentiation in rat hippocampus in vivo
- 28 November 2008
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 450 (3) , 306-310
- https://doi.org/10.1016/j.neulet.2008.11.053
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Haploinsufficiency of the arginine–vasopressin gene is associated with poor spatial working memory performance in ratsHormones and Behavior, 2006
- An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over‐express a mutant form of human APP associated with Alzheimer's diseaseEuropean Journal of Neuroscience, 2004
- Effects of arginine-vasopressin (AVP) on long-term potentiation in intact anesthetized ratsBrain Research Bulletin, 2002
- Arginine vasopressin fragment AVP(4-9)facilitates induction of long-term potentiation in the hippocampus.Bulletin of Experimental Biology and Medicine, 2001
- Vasopressin and memoryBehavioural Brain Research, 1997
- Behavioral Consequences of Intracerebral Vasopressin and Oxytocin: Focus on Learning and MemoryNeuroscience & Biobehavioral Reviews, 1996
- Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4–8)Brain Research, 1995
- The Ca2+ influx induced by β‐amyloid peptide 25–35 in cultured hippocampal neurons results from network excitationJournal of Neurobiology, 1995
- Neuromodulation: Associative and nonlinear adaptationBrain Research Bulletin, 1990
- Vasopressin neuromodulation in the hippocampusJournal of Neuroscience, 1989